किडनी फेल्योर का सबसे अच्छा इलाज — दानदाता से स्वस्थ किडनी रोगी में प्रत्यारोपित करना। भारत में जीवित दान (परिवार से) आम है; कैडेवर ट्रांसप्लांट बढ़ रहा है। ट्रांसप्लांट के बाद इम्यूनोसप्रेसेंट जीवनभर लेने पड़ते हैं।
Kidney transplantation provides the best long-term outcomes for ESRD patients with superior survival, quality of life, and lower costs compared to long-term dialysis. One-year graft survival rates: living donor — 95-98%, deceased donor — 90-95%. Half-life for deceased donor grafts is approximately 10-12 years. Pre-transplant evaluation includes: cardiac and pulmonary assessment, malignancy screening, infection workup, tissue typing (HLA matching), and crossmatch testing. Immunosuppression typically includes induction (anti-thymocyte globulin or basiliximab) and maintenance (tacrolimus + mycophenolate mofetil + prednisone). Post-transplant complications: acute rejection (10-20% in first year), infections (CMV, BK virus), cardiovascular disease (leading cause of death post-transplant), and post-transplant diabetes. Pre-emptive transplant (before dialysis initiation) offers the best outcomes.
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.